Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -38.70% is 35% below its 5-year average of -28.76%, around the middle of its 5-year range (-73.00%–11.17%).
As of the fiscal period ended Tuesday, June 30, 2026. 25.56% below its 12-month average of -30.82%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -38.70%.
RETURN ON INVESTED CAPITAL (ROIC)
-38.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-30.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-36.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-28.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-25.56%
CURRENT VS 3Y AVG
-6.33%
CURRENT VS 5Y AVG
-34.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-8.58%
vs the sector median at left
NewAmsterdam Pharma Company N.V.
Market Cap
$2.58B
Return on Invested Capital (ROIC)
-38.70%
TTM Avg
-30.82%
3Y Avg
-36.40%
5Y Avg
-28.76%
Market Cap
$2.57B
Return on Invested Capital (ROIC)
0.00%
TTM Avg
2.20%
3Y Avg
0.80%
5Y Avg
-4.44%
Market Cap
$2.58B
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-36.25%
3Y Avg
-29.21%
5Y Avg
-30.95%
Market Cap
$2.60B
Return on Invested Capital (ROIC)
-0.68%
TTM Avg
-0.20%
3Y Avg
0.55%
5Y Avg
2.38%
Market Cap
$2.67B
Return on Invested Capital (ROIC)
15.45%
TTM Avg
14.86%
3Y Avg
6.92%
5Y Avg
-8.67%
Market Cap
$2.47B
Return on Invested Capital (ROIC)
-10.24%
TTM Avg
1.21%
3Y Avg
1.35%
5Y Avg
3.39%
Market Cap
$2.69B
Return on Invested Capital (ROIC)
6.69%
TTM Avg
7.54%
3Y Avg
8.48%
5Y Avg
6.84%
Market Cap
$2.71B
Return on Invested Capital (ROIC)
-28.60%
TTM Avg
-26.51%
3Y Avg
-39.35%
5Y Avg
-39.35%
Market Cap
$2.69B
Return on Invested Capital (ROIC)
-28.02%
TTM Avg
-99.23%
3Y Avg
-79.58%
5Y Avg
-63.04%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Company N.V. (NAMS) | $2.58B | -38.70% | -30.82% | -36.40% | -28.76% |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 0.00% | 2.20% | 0.80% | -4.44% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.58B | -28.96% | -36.25% | -29.21% | -30.95% |
| Neogen Corporation (NEOG)vs › | $2.60B | -0.68% | -0.20% | 0.55% | 2.38% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.67B | 15.45% | 14.86% | 6.92% | -8.67% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.47B | -10.24% | 1.21% | 1.35% | 3.39% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 6.69% | 7.54% | 8.48% | 6.84% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | -28.60% | -26.51% | -39.35% | -39.35% |
| Precigen, Inc. (PGEN)vs › | $2.69B | -28.02% | -99.23% | -79.58% | -63.04% |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 2.04% | -4.01% | -5.25% | -2.96% |
ROIC
-38.7%
ROE
-41.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -38.70% |
| 2026-03-31 | -32.35% |
| 2025-12-31 | -33.01% |
| 2025-09-30 | -27.87% |
| 2025-06-30 | -22.19% |
| 2025-03-31 | -24.39% |
| 2024-12-31 | -23.20% |
| 2024-09-30 | -46.14% |
| 2024-06-30 | -51.86% |
| 2024-03-31 | -46.20% |
| 2023-12-31 | -61.56% |
| 2023-06-30 | -29.31% |
| 2022-12-31 | 0.36% |
| 2022-09-30 | 2.64% |
| 2022-06-30 | 11.17% |
| 2022-03-31 | -2.79% |
| 2021-12-31 | -73.00% |
| 2021-09-30 | -40.74% |
| 2021-06-30 | -7.23% |
| 2021-03-31 | -9.71% |
| 2020-12-31 | -8.23% |
